H.R. 1492 · 115th Congress
Medical Controlled Substances Transportation Act of 2017
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
No cosponsors.
- House Introduced Mar 10, 2017
- House Passed Jul 12, 2017 416–2
What it does: CRS summary · Passed House without amendment · Jul 12, 2017
(This measure has not been amended since it was introduced. The expanded summary of the House reported version is repeated here.)
Medical Controlled Substances Transportation Act of 2017
(Sec. 2) This bill amends the Controlled Substances Act to direct the Drug Enforcement Administration to register practitioners (other than pharmacies) to transport controlled substances to and administer controlled substances in other states.
A registered practitioner must: be licensed, registered, or authorized to administer controlled substances in the other state; limit the duration of transport to 72 consecutive hours; and comply with recordkeeping requirements.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
Votes to become law
About this bill and sources
Official title: Medical Controlled Substances Transportation Act of 2017
Latest action (Jul 13, 2017): Received in the Senate and Read twice and referred to the Committee on the Judiciary.
Policy area: Crime and Law Enforcement · Origin: House · Introduced: Mar 10, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML) · Embed in your story
- House Introduced Mar 10, 2017
- House Passed Jul 12, 2017 416–2
Final vote · House · Jul 12, 2017
Passage (two-thirds required) — Passed. Vote details
Speaker of the House: Paul D. Ryan